Are peptides legal in Massachusetts?
Peptide drugs are federally regulated. State pharmacy law governs compounding and dispensing, and the state board follows FDA 503A/503B bulk-substance rules. After the 2012 NECC meningitis outbreak, Massachusetts adopted the nation's strictest sterile-compounding inspection regime, which limits availability of injectable peptide preparations.
Compounding
Heightened post-NECC compounding oversight
Primary citations
- M.G.L. c. 112 § 39D
- 247 CMR 17.00
What this means practically
Approved peptide drugs such as semaglutide, tirzepatide, and tesamorelin are obtainable in Massachusetts with a valid prescription from a licensed practitioner, dispensed by a licensed pharmacy. Telehealth access is permitted.
Peptides on the FDA's 503A Category 2 bulk list — including BPC-157, CJC-1295, ipamorelin, and thymosin alpha-1 — cannot lawfully be compounded by any pharmacy in Massachusetts, regardless of state rules, because the restriction is federal. Products sold online as "research chemicals" are not approved for human use.
This page tracks status only. It is not legal advice, and state boards update guidance frequently.